Leadiant Biosciences, Inc.
16
0
1
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
25.0%
4 terminated/withdrawn out of 16 trials
73.3%
-13.2% vs industry average
19%
3 trials in Phase 3/4
45%
5 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
Multi-Center Study of ManNAc for GNE Myopathy
Role: lead
Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy
Role: collaborator
A Study of Chenodeoxycholic Acid (CDCA) in Newly Diagnosed Participants With Cerebrotendinous Xanthomatosis (CTX)
Role: lead
Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patients With Spinal Muscular Atrophy
Role: collaborator
Chemotherapy With Liposomal Cytarabine CNS Prophylaxis for Adult Acute Lymphoblastic Leukemia & Lymphoblastic Lymphoma
Role: collaborator
EZN-2279 in Patients With ADA-SCID
Role: lead
STP206 for the Prevention of Necrotizing Enterocolitis (NEC)
Role: lead
A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma
Role: collaborator
Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage
Role: collaborator
CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I
Role: collaborator
Randomized Study of New Formulation Ophthalmic Cysteamine Hydrochloride for Corneal Cystine Accumulation in Patients With Cystinosis
Role: collaborator
Effect of Chronic Intranasal Oxytocin Administration on Sexual Function in Pre- and Postmenopausal Women
Role: collaborator
Safety and Tolerability of STP206 in Healthy Adult Subjects
Role: lead
Acetyl-L-Carnitine in Type 2 Diabetes
Role: collaborator
Carnitine Levels and Carnitine Supplementation in Type I Diabetes
Role: collaborator
Confocal Endomicroscopy for Biliary Strictures -Phase I
Role: collaborator
All 16 trials loaded